Thrivent Financial for Lutherans’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70,544	Closed	-$809K	–	2555
2023 Q3	$809K	Sell	70,544 -3,176,775	-98%	-$36.4M	﹤0.01%	1872
2023 Q2	$82.2M	Buy	3,247,319 +1,226,338	+61%	+$31M	0.19%	157
2023 Q1	$65.1M	Buy	2,020,981 +1,946,680	+2,620%	+$62.7M	0.16%	180
2022 Q4	$1.37M	Buy	+74,301	New	+$1.37M	﹤0.01%	1526